Stock 4166 ORIENT PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Orient Pharma Co., Ltd.

Equities

4166

TW0004166004

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-05 pm EDT 		5-day change 1st Jan Change
28 TWD +6.46% Intraday chart for Orient Pharma Co., Ltd. +23.89% +40.00%
Apr. 15 Orient Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Orient Pharma Co., Ltd. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of western medicines. The Company's main products include hyperlipidemic drugs, diabetes drugs, cardiovascular drugs and drugs for musculoskeletal diseases. The Company is also involved in the original equipment manufacturer (OEM) manufacturing business and clinical trial business. The Company distributes its products in domestic market and to overseas markets, such as the United States, Ireland and mainland China.

Number of employees: 173

Sales per Business

TWD in Million2022Weight2023Weight Delta
Factory Operations
95.2 %
446 87.2 % 847 95.2 % +89.82%
Global Business
4.4 %
63 12.3 % 39 4.4 % -38.14%
Medical Affairs
0.4 %
3 0.5 % 4 0.4 % +50.24%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
76.4 %
254 49.6 % 680 76.4 % +167.88%
United States
20.1 %
216 42.2 % 178 20.1 % -17.46%
Philippines
2.7 %
-- 24 2.7 % -
Others
0.9 %
4 0.8 % 8 0.9 % +99.23%
China
0.0 %
38 7.4 % 0 0.0 % -99.95%

Managers

Managers TitleAgeSince
Chi Tai Chang CEO
 Chief Executive Officer - -
Chia Ying Chen DFI
 Director of Finance/CFO - -
Meng Lin Tsai BRD
 Director/Board Member - -

Members of the board

Members of the board TitleAgeSince
Cheng Hung Tsai CHM
 Chairman - 08-01-14
Wei Chao Kao BRD
 Director/Board Member - -
Han Liang Hu BRD
 Director/Board Member 57 -
Tai Ming Chen BRD
 Director/Board Member - 16-06-22
Yu Ling Li BRD
 Director/Board Member - -
Wen Hung Huang BRD
 Director/Board Member - -
Wen Chieh Sung BRD
 Director/Board Member - -
Ko Hsin Hu BRD
 Director/Board Member - -
Chia Yue Chang BRD
 Director/Board Member - -
Sheng Che Lin BRD
 Director/Board Member - 19-06-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 223,035,000 34,031,431 ( 15.26 %) 0 15.26 %

Company contact information

Orient Pharma Co., Ltd.

2nd Floor 368, Section 1, Fuhsing South Road

106 56, Taipei

+

http://www.oppharma.com
address Orient Pharma Co., Ltd.(4166)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ORIENT PHARMA CO., LTD. Stock Orient Pharma Co., Ltd.
+40.00% 182M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.94% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.96% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.27% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.01% 323B
ABBVIE INC. Stock AbbVie Inc.
+4.77% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.81% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.63% 194B
AMGEN INC. Stock Amgen Inc.
+3.96% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4166 Stock
  4. Company Orient Pharma Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW